Prevalence of Drug-Drug Interactions in Hypertensive Patients in Secondary Care Teaching Hospital

Authors

  • D. Priyanka Department of Pharmacy Practice, Balaji College of Pharmacy, Anantapuramu, A.P, India Author
  • S. Swathi Department of Pharmacy Practice, Balaji College of Pharmacy, Anantapuramu, A.P, India Author
  • B. Naga Roopini Department of Pharmacy Practice, Balaji College of Pharmacy, Anantapuramu, A.P, India Author
  • T. Rajavardhana Department of Pharmacy Practice, Balaji College of Pharmacy, Anantapuramu, A.P, India Author

DOI:

https://doi.org/10.30904/

Keywords:

Drug-Drug interactions, hypertension, angiotensin converting enzymes, prescriptions, captopril

Abstract

A drug-drug interaction (DDI) occurs when two (or more) drugs are administered concomitantly and another one, with the result of either increasing or decreasing the effect of the object drug, or producing a new and unanticipated effect (1), alters the pharmacological effects of one drug. Drug-Drug Interactions are considered to be beneficial or harmful and depend on several factors related to the type of medication, the patient or the conditions under which the medication is used (2). The harmful consequences of Drug-Drug Interactions range from minor morbidities to fatal consequences

Downloads

Published

2016-12-29

Issue

Vol. 3 No. 02 (2016): WJPBT

Section

Articles

License

Copyright (c) 2016 Author

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

D, P., S, S., B, N. R., & T, R. (2016). Prevalence of Drug-Drug Interactions in Hypertensive Patients in Secondary Care Teaching Hospital. World Journal of Pharmacy and Biotechnology, 3(02), 65-69. https://doi.org/10.30904/